A detailed history of Pictet & Cie (Europe) Sa transactions in Pfizer Inc stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 10,100 shares of PFE stock, worth $266,236. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,100
Previous 10,100 -0.0%
Holding current value
$266,236
Previous $282,000 3.55%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $330,906 - $387,760
-13,100 Reduced 56.47%
10,100 $282,000
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $51,780 - $59,460
2,000 Added 9.43%
23,200 $643,000
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $105,147 - $136,574
-4,024 Reduced 15.95%
21,200 $610,000
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $909,751 - $1.06 Million
-28,350 Reduced 52.92%
25,224 $836,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $81,089 - $93,818
-2,245 Reduced 4.02%
53,574 $1.97 Million
Q1 2023

May 01, 2023

SELL
$39.39 - $51.28 $445,816 - $580,387
-11,318 Reduced 16.86%
55,819 $2.28 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $113,727 - $148,458
-2,724 Reduced 3.9%
67,137 $0
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $288,816 - $352,572
6,600 Added 10.43%
69,861 $3.06 Billion
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $374,101 - $443,566
8,040 Added 14.56%
63,261 $3.32 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $359,320 - $445,243
7,854 Added 16.58%
55,221 $2.86 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $1.1 Million - $1.42 Million
28,076 Added 145.54%
47,367 $2.04 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $7,612 - $8,624
212 Added 1.11%
19,291 $755,000
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $716,116 - $807,635
-21,383 Reduced 52.85%
19,079 $691,000
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $467,542 - $594,520
13,969 Added 52.73%
40,462 $1.49 Million
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $112,395 - $131,865
-3,540 Reduced 11.79%
26,493 $972,000
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $212,586 - $257,899
-7,058 Reduced 19.03%
30,033 $982,000
Q1 2020

Apr 30, 2020

BUY
$27.03 - $38.62 $125,202 - $178,887
4,632 Added 14.27%
37,091 $1.21 Million
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $19,554 - $22,191
594 Added 1.86%
32,459 $1.27 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $100,719 - $130,603
3,100 Added 10.78%
31,865 $1.15 Million
Q2 2019

Aug 07, 2019

SELL
$36.98 - $41.52 $151,359 - $169,941
-4,093 Reduced 12.46%
28,765 $1.25 Million
Q1 2019

May 01, 2019

BUY
$37.5 - $41.2 $97,050 - $106,625
2,588 Added 8.55%
32,858 $1.4 Million
Q4 2018

Jan 31, 2019

SELL
$38.47 - $43.86 $215,816 - $246,054
-5,610 Reduced 15.64%
30,270 $1.32 Million
Q3 2018

Nov 07, 2018

SELL
$34.47 - $41.81 $30,057 - $36,458
-872 Reduced 2.37%
35,880 $1.58 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $321,884 - $343,161
-9,760 Reduced 20.98%
36,752 $1.33 Million
Q1 2018

May 09, 2018

BUY
$31.91 - $37.02 $405,959 - $470,968
12,722 Added 37.65%
46,512 $1.65 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $286,036 - $303,494
8,600 Added 34.14%
33,790 $1.22 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $262,880 - $289,592
8,480 Added 50.75%
25,190 $899,000
Q2 2017

Aug 09, 2017

BUY
N/A
16,710
16,710 $561,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.